SCHEMBL7738709

SCHEMBL7738709

CCOc1ccc2[nH]cc(C(=O)NC(C)CC)c(=O)c2c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.73
TP53 P04637 4/20 0.73
USP2 O75604 2/20 0.73
ALOX15 P16050 1/20 0.73
POLB P06746 3/20 0.64
KDM4E B2RXH2 5/20 0.63
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HTT P42858 3/20 0.58
ALDH1A1 P00352 3/20 0.56
HPGD P15428 3/20 0.56
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
MAPT P10636 5/20 0.51
GAA P10253 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208453 0.87 POLB (0.60) HSD17B10TP53USP2ALOX15POLB
SCHEMBL6205462 0.87 POLB (0.62) HSD17B10TP53USP2ALOX15POLB
SCHEMBL6205435 0.87 POLB (0.62) HSD17B10TP53USP2ALOX15POLB
SCHEMBL7738707 0.84 POLB (0.70) HSD17B10TP53USP2ALOX15POLB
SCHEMBL2010976 0.83 HTT (0.81) HSD17B10POLBKDM4EMEN1KMT2A
SCHEMBL7740429 0.82 KDM4E (0.78) HSD17B10TP53USP2POLBKDM4E
SCHEMBL6208099 0.81 POLB (0.66) HSD17B10TP53USP2ALOX15POLB
SCHEMBL6204810 0.80 POLB (0.88) HSD17B10TP53USP2POLBKDM4E
SCHEMBL6204275 0.80 HTT (0.64) HSD17B10TP53POLBKDM4EMEN1
SCHEMBL6204768 0.79 KDM4E (0.80) HSD17B10TP53USP2POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed